Professional
Added to YB: 2025-10-17
Pitch date: 2025-10-14
BIO [bullish]
Bio-Rad Laboratories, Inc.
-11.88%
current return
Author Info
No bio for this author
Company Info
Bio-Rad Laboratories, Inc. develops, manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, Latin America, and internationally.
Market Cap
$6.9B
Pitch Price
$308.54
Price Target
N/A
Dividend
N/A
EV/EBITDA
11.98
P/E
9.21
EV/Sales
2.62
Sector
Life Sciences Tools and Services
Category
value
Upslope Capital Portfolio Holding: Bio-Rad Laboratories, Inc.
BIO (holding update): Global diagnostic/life sciences leader w/ 70% recurring sales, owns 35% of Sartorius (SRT-DE) representing ~50% of enterprise value. Core biz trades at 9x 2026 EBITDA after adjusting for SRT stake - well below peers. Both recovering from COVID hangover, fundamentals likely troughing.
Read full article (1 min)